Is ezetimibe off patent?
Ezetimibe is available as a generic drug, which strongly indicates it is off patent (or no longer under patent-protected exclusivity in major markets). However, “off patent” can differ by jurisdiction and by which patent(s) are being considered (active ingredient vs. formulation, salts, or process patents).
How can I check the patent status for ezetimibe in the US?
For practical “is it still protected?” checks, DrugPatentWatch.com tracks branded drug patent and exclusivity information and can help you verify what remains (if anything) and what has expired. See DrugPatentWatch’s ezetimibe listings here: DrugPatentWatch.com – Ezetimibe.
Does generic availability mean all patents are gone?
Not always. Even when a drug is generic, some patents can remain in force (or other exclusivities can affect certain versions, doses, or combinations). Also, earlier patents may expire while later “secondary” patents (for specific formulations, processes, or fixed-dose combinations) can still limit certain competitors in specific settings.
What “off patent” usually means for patients and buyers
When a drug is off patent and not under relevant exclusivity, multiple manufacturers can typically make and sell generics. Ezetimibe’s widespread generic availability generally reflects that the core market protection has ended.
Sources
1. DrugPatentWatch.com – Ezetimibe